The Tony Torbey ICU Family Communication Fund at UNMH
Position Statement: Neurocritical Care Resource Utilization in Pandemics
This fund is in honor of the father of Dr. Michel Torbey, UNM Professor, Chair of Neurology/Neurointensivist, and father-in-law of Dr. Diana Greene-Chandos, UNM Associate Professor of Neurology/Neurointensivst, who lost his life to COVID-19. The funds will be used to purchase large screen iPads to be mounted on a rolling pole (with a location tag) so families to have visual time with a loved ones in the ICU through secure zoom calls.
Click here to donate.
Neurocritical Care Journal
On this episode of the NCS Podcast Series, Dr. Fawaz Al-Mufti is joined by Drs. Neha Dangayach, Anne Lipke, and Chris Zammit to discuss their experience working with patients diagnosed with COVID-19.Click here to listen to Episode 33: COVID-19 and the Critical Care Experience
Click below to watch the recorded webinar in which Chris Robinson, DO, MS, Clinical Assistant Professor at the University of Florida, discusses the neurologic effects of COVID-19. This webinar is posted in the Respiratory Support of the Neurocritically Ill chapter of Neurocritical Care ON CALL
. Click here to watch
Online Discussion Forum (Members Only)
View recent discussions regarding COVID-19
In an effort to help all health care professionals as they fight the COVID-19 pandemic, NCS has provided free access to select educational products. Please click below to access these free resources.
Ethics Curriculum for NCC Fellowships
Ethics Curriculum: Decision Making Support webinar
Medical Futility webinar
Moral Distress webinar
Law and Ethics in Neurocritical Care
Ch 1. Principles of Ethics
Ch. 3 Ethics in Medicine
Ch.5 Duty of Restraint
Ch.6 Rationing of Medical Services
Ch. 7 Drug Shortages and Patient Care
Ch.13 Medical Futility and Medically Inappropriate Care
Ch.18 Palliative Care Consultation in the ICU
Ch. 21 Provider Burnout
Ch. 32 Terminal Withdrawal of Life Support
Ch. 34 Compassionate/Terminal Extubation
Ch. 46 Off-Label Use
Help determine the impact of COVID-19 on neurological conditions by participating in our Global Consortium Study of Neurological Dysfunction in COVID 19 (GCS NeuroCOVID study). A full description of our methods paper is listed here. The study is led by Dr. Sherry Chou, MD, MSc and Dr. Molly McNett, PhD, RN, with the data coordinating center housed at the University of Pittsburgh. There are over 200 sites currently participating in the consortium, with global representation from over 30 countries. The study is supported by the Neurocritical Care Society (NCS), the Neurocritical Care Research Network (NCRN), and the Clinical Translational Science Institute from the University of Pittsburgh.
Registration is now closed for the studies below. Please email firstname.lastname@example.org if you would like additional information.
NCC COVID 19 OUTCOMES: This study is a prospective cohort observational study to determine the impact of COVID 19 crisis on resource allocation and outcomes of ICU patients with acute neurological injury who require routine care and are not necessarily COVID 19 positive. The study will evaluate mortality and functional outcomes at hospital discharge and 90 days among critically ill, neurologically impaired patients admitted during the COVID 19 crisis period. Participating sites have the option to also compare those outcomes to a historical control group who were treated prior to the COVID 19 crisis.
NCC COVID 19 MANIFESTATIONS: This study is a prospective observational cohort study to document prevalence and severity of neurological symptoms among patients with confirmed or suspected novel coronavirus (COVID 19). This study contains common data elements that all sites are requested to obtain (Tier 1 data), as well as supplemental data elements that are optional for sites to obtain retrospectively based on time and resources. This study will also offer optional addendums to investigate Tier 2 and Tier 3 strategies, such as more invasive blood and tissue sampling, based on local resources.
NCC COVID 19 MANIFESTATIONS IN PEDIATRIC PATIENTS: This study is an observational cohort study to document prevalence and severity of neurological symptoms among patients younger than 18 years old admitted to the hospital with confirmed or presumed novel coronavirus (COVID 19). This study contains common data elements that all sites are requested to obtain (Tier 1 data). Tier 1 data are generally obtainable from electronic medical records and similar sources, under an IRB protocol allowing waiver of consent. Interested sites may also collect Tier 2 data such as standardized outcome measures at a later time point (~ 1 month after hospital discharge). A second IRB for tier 2 data would require informed consent, as would the process of data sharing outside the institution.
Help our NeuroHeroes Fight COVID-19
Many healthcare practitioners treating COVID-19 patients are working 12-hour+ shifts with little time to eat or take a break. A multi-center, multidisciplinary team initiated by NCS members has organized food delivery to lift morale, support, and show solidarity for several NeuroICUs in high-impact cities nationwide.DONATE NOW